Tools
Tools
Rutella, S. 
ORCID: 0000-0003-1970-7375, Cannarile, M.A., Gnjatic, S., Gomes, B., Guinney, J., Karanikas, V., Karkada, M., Kirkwood, J.M., Kotlan, B., Masucci, G.V., Meeusen, E., Monette, A., Naing, A., Thorsson, V., Tschernia, N., Wang, E., Wells, D.K., Wyant, T.L. and Cesano, A.,
2020.
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I—conceptual challenges.
Journal for ImmunoTherapy of Cancer, 8 (2): e001389.
ISSN 2051-1426
|
Text
1383370_Rutella.pdf - Published version Download (308kB) | Preview |
Abstract
The sharing of clinical trial data and biomarker data sets among the scientific community, whether the data originates from pharmaceutical companies or academic institutions, is of critical importance to enable the development of new and improved cancer immunotherapy modalities. Through data sharing, a better understanding of current therapies in terms of their efficacy, safety and biomarker data profiles can be achieved. However, the sharing of these data sets involves a number of stakeholder groups including patients, researchers, private industry, scientific journals and professional societies. Each of these stakeholder groups has differing interests in the use and sharing of clinical trial and biomarker data, and the conflicts caused by these differing interests represent significant obstacles to effective, widespread sharing of data. Thus, the Society for Immunotherapy of Cancer (SITC) Biomarkers Committee convened to identify the current barriers to biomarker data sharing in immuno-oncology (IO) and to help in establishing professional standards for the responsible sharing of clinical trial data. The conclusions of the committee are described in two position papers: Volume I-conceptual challenges and Volume II-practical challenges, the first of which is presented in this manuscript. Additionally, the committee suggests actions by key stakeholders in the field (including organizations and professional societies) as the best path forward, encouraging the cultural shift needed to ensure responsible data sharing in the IO research setting.
| Item Type: | Journal article | ||||||
|---|---|---|---|---|---|---|---|
| Publication Title: | Journal for ImmunoTherapy of Cancer | ||||||
| Creators: | Rutella, S., Cannarile, M.A., Gnjatic, S., Gomes, B., Guinney, J., Karanikas, V., Karkada, M., Kirkwood, J.M., Kotlan, B., Masucci, G.V., Meeusen, E., Monette, A., Naing, A., Thorsson, V., Tschernia, N., Wang, E., Wells, D.K., Wyant, T.L. and Cesano, A. | ||||||
| Publisher: | BioMed Central | ||||||
| Date: | October 2020 | ||||||
| Volume: | 8 | ||||||
| Number: | 2 | ||||||
| ISSN: | 2051-1426 | ||||||
| Identifiers: |
|
||||||
| Rights: | Copyright information: © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/. | ||||||
| Divisions: | Schools > School of Science and Technology | ||||||
| Record created by: | Linda Sullivan | ||||||
| Date Added: | 02 Nov 2020 12:03 | ||||||
| Last Modified: | 31 May 2021 15:14 | ||||||
| URI: | https://irep.ntu.ac.uk/id/eprint/41454 |
Actions (login required)
 |
Edit View |
Views
Views per month over past year
Downloads
Downloads per month over past year
